Cannabinoids are small organic molecules that bind to specialized receptors on cells within the body and brain. Several different cannabinoids have been identified as naturally occurring and continue to be studied to better understand potential therapeutic effects on the body. While potency testing for d9-THC and CBD content is required for federal classification of marijuana vs. hemp, full cannabinoid profile testing is critical to understanding a specific product’s potential therapeutic effects.
Understanding a product’s true cannabinoid profile and appropriate dose or serving size may aid patients, healthcare providers, and other legal adult-use consumers in having an information-driven conversation about their desired therapeutic experience and establishing a cannabis regiment to maximize their potential health benefits while minimizing unwanted or unintended effects. Patients, prescribers, and adult-use consumers can confidently achieve accurate dosing when using products analyzed by US Cannalytics.
US Cannalytics utilizes high-performance liquid chromatography (HPLC) coupled with diode array detection (DAD) to quantify the concentrations of up to 17 active cannabinoids in virtually any known sample matrix.
We analyze all medical and adult-use cannabis samples utilizing our ISO / IEC 17025:2017 accredited methods for cannabinoid potency.
| THCa | Tetrahydrocannabinolic Acid |
| Δ9-THC | Delta-9-tetrahydrocannabinol |
| Δ8-THC | Delta-8-tetrahydrocannabinol |
| THCVa | Tetrahydrocannabivarinic Acid |
| THCV | Tetrahydrocannabivarin |
| CBDa | Cannabidiolic Acid |
| CBD | Cannabidiol |
| CBDVa | Cannabidivarinic Acid |
| CBDV | Cannabidivarin |
| CBNa | Cannabinolic Acid |
| CBN | Cannabinol |
| CBGa | Cannabigerolic Acid |
| CBG | Cannabigerol |
| CBCa | Cannabichromenic Acid |
| CBC | Cannabichromene |
| CBLa | Cannabicyclolic Acid |
| CBL | Cannabicyclol |
